ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Established Pharmaceutical Company Makes a High-profile Entrance with "Unlimited" R&D Investment, Signaling an Imminent Explosion in This Emerging Field
December 20, 2024Recently, Northeast Pharm announced its plan to acquire a 70% stock equity in Dingcheng Taiyuan for a total cash consideration of approximately RMB 187 million, thereby obtaining controlling stake in the company. -
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19
October 22, 2020Poseida Therapeutics, Inc. and TScan Therapeutics, Inc. announced a research collaboration and license agreement to explore developing TCR-T cell therapies for the treatment of COVID-19.
Pharma Sources Insight January 2025
